SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0000882104-21-000027
Filing Date
2021-02-02
Accepted
2021-02-02 16:20:00
Documents
1
Reference 429
333-220435

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 a20210202s-8doc.htm POS AM 45574
  Complete submission text file 0000882104-21-000027.txt   46713
Mailing Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521
Business Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-220435 | Film No.: 21581708
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences